Cargando…
Site-Selective Functionalized PD-1 Mutant for a Modular Immunological Activity against Cancer Cells
[Image: see text] Targeting immune checkpoints is a well-established strategy in cancer therapy, and antibodies blocking PD-1/PD-L1 interactions to restore the immunological activity against cancer cells have been clinically validated. High-affinity mutants of the PD-1 ectodomain have recently been...
Autores principales: | Fallarini, Silvia, Cerofolini, Linda, Salobehaj, Maria, Rizzo, Domenico, Gheorghita, Giulia Roxana, Licciardi, Giulia, Capialbi, Daniela Eloisa, Zullo, Valerio, Sodini, Andrea, Nativi, Cristina, Fragai, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646970/ https://www.ncbi.nlm.nih.gov/pubmed/37902625 http://dx.doi.org/10.1021/acs.biomac.3c00893 |
Ejemplares similares
-
Fucosylated ubiquitin and orthogonally glycosylated mutant A28C: conceptually new ligands for Burkholderia ambifaria lectin (BambL)
por: Kuhaudomlarp, Sakonwan, et al.
Publicado: (2020) -
Large Protein
Assemblies for High-Relaxivity Contrast
Agents: The Case of Gadolinium-Labeled Asparaginase
por: Licciardi, Giulia, et al.
Publicado: (2022) -
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design
por: Donati, Greta, et al.
Publicado: (2023) -
Not only manganese, but fruit component effects dictate the efficiency of fruit juice as an oral magnetic resonance imaging contrast agent
por: Licciardi, Giulia, et al.
Publicado: (2021) -
Niosomes
as Biocompatible Scaffolds for the Multivalent
Presentation of Tumor-Associated Antigens (TACAs) to the Immune System
por: Fallarini, Silvia, et al.
Publicado: (2022)